Biotech veteran joins CancerVax as scientific advisor
Dr. George Kemble, former AstraZeneca executive, joins CancerVax as Senior Scientific Advisor to advise on immunological and viral strategies for cancer treatment platform.
CancerVax reports success in nanoparticle component tests
CancerVax's in-vitro studies show strong uptake of cell-targeting nanoparticles by cancer cells and activation of Smart mRNAs, preparing for animal studies.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.